Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nellix Endovascular Inc.

Division of Endologix Inc.
www.nellix.com

Latest From Nellix Endovascular Inc.

People Briefs

CardioDx appoints president and CEO; FDA device review veteran joins Hogan Lovells; TransEnterix names new senior surgical office; and more personnel updates from around the industry.

Medical Device Business Strategies

Weak Gains Seen In Stock-Based Device Deals

Sellers can’t be choosers in a down market. But an analysis of recent device acquisitions shows that share prices of the acquiring company included in compensation more often than not lose rather than gain value.

Medical Device United States

EVAR Market: Challenges, Innovation and Growth

Endovascular aortic aneurysm repair procedures account for the majority of abdominal aortic aneurysm repairs performed in the US, and total worldwide revenues from aortic endograft systems now exceed $1 billion per year. Many believe that continuing improvements in endograft technology will drive EVAR penetration to 90% or beyond within the next five to 10 years. This article first appeared in the April issue of Medtech Insight, April 2011.

BioStar Could Light Path For Device Investors

BioStar Ventures, founded by physicians who are leaders in the interventional cardiology field, is demonstrating how medical device investors might benefit with close ties to clinical and corporate worlds.
North America
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
      • Surgical Sealants
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Endologix Inc.
  • Senior Management
  • Robert D Mitchell, Pres. & CEO
    Doug Hughes, CFO
    K.T. Rao, VP, R&D & CSO
  • Contact Info
  • Nellix Endovascular Inc.
    Phone: (650) 213-8700
    2465-B Faber Pl.
    Palo Alto, CA 94303
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register